MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from ipo, net of
commissions and issuance...
$64,212K
Proceeds from the
issuance of convertible...
$39,863K
Proceeds from series e
convertible preferred...
$39,508K
Proceeds from exercise of
common stock options
$919K
Proceeds from exercise of
preferred stock warrants
$455K
Net cash provided in
financing activities
$144,957K
Net change in cash
for period
$20,748K
Canceled cashflow
$124,209K
Sales of marketable
securities
$31,302K
Change in fair value of
warrant liabilities and...
$11,975K
Accounts payable
$3,369K
Depreciation and
amortization
$3,208K
Change in fair value of
convertible notes, net
$2,217K
Other current assets
and liabilities
-$1,902K
Stock compensation
expense
$996K
Amortization of debt
discounts
$253K
Credit losses, net of
recoveries
$153K
Loss on disposal of
long-lived assets
-$100K
Net cash provided
(used) in investing...
-$95,597K
Net cash used in
operating activities
-$28,612K
Canceled cashflow
$31,302K
Canceled cashflow
$24,173K
Gross profit
$36,202K
Purchases of marketable
securities
$119,491K
Net loss
-$40,359K
Fixed asset purchases
$7,408K
Canceled cashflow
$36,202K
Inventory
$7,636K
Trade accounts
receivable
$3,299K
Prepaid expenses
$1,087K
Realized gain on
marketable securities
$404K
General and
administrative
$26,234K
Sales and marketing
$23,545K
Interest/other expense
-$14,062K
Research and development
$7,731K
Medical education
$4,989K
Back
Back
Cash Flow
source: myfinsight.com
SHOULDER INNOVATIONS, INC. (SI)
SHOULDER INNOVATIONS, INC. (SI)